ArticleNature2020
A race to determine what drives COVID-19 severity.
Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy of tocilizumab treatment in severely ill COVID-19 patients.Critical care (London, England) · 2020Pooled it
- Differences in Susceptibility to SARS-CoV-2 Infection Among Transgenic hACE2-Hamster Founder Lines.Viruses · 2024Article
- Preclinical study of formulated recombinant nucleocapsid protein, the receptor binding domain of the spike protein, and truncated spike (S1) protein as vaccine candidates against COVID-19 in animal models.Molecular immunology · 2022Article
- Obesity: an evolutionary context.Life metabolism · 2022Review
- SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity.Nature communications · 2022Article
- Impact of the SARS-CoV-2 virus on male reproductive health.BJU international · 2022Review
- Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study.Frontiers in pharmacology · 2022Article
- Publication trends of research on COVID-19 and host immune response: A bibliometric analysis.Frontiers in public health · 2022Review
- Mortality Predictors in Severe COVID-19 Patients from an East European Tertiary Center: A Never-Ending Challenge for a No Happy Ending Pandemic.Journal of clinical medicine · 2021Article
- Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity.Research square · 2021Article
- Article
- Integrated immune dynamics define correlates of COVID-19 severity and antibody responses.Cell reports. Medicine · 2021Article
- Article
- How Our Neanderthal Genes Affect the COVID-19 Mortality: Iran and Mongolia, Two Countries with the Same SARS-CoV-2 Mutation Cluster but Different Mortality Rates.Journal of biomedical physics & engineering · 2021Article
- Insights on the Structural Variations of the Furin-Like Cleavage Site Found Among the December 2019-July 2020 SARS-CoV-2 Spike Glycoprotein: A Computational Study Linking Viral Evolution and Infection.Frontiers in medicine · 2021Article
- A Systematic Analysis on COVID-19 Patients in Inner Mongolia Based on Dynamic Monitoring.BioMed research international · 2021Article
- Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients.Frontiers in immunology · 2021Article
- Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease.Scientific reports · 2020Article
- Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease.bioRxiv : the preprint server for biology · 2020Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
32661414What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.